Table 1.
Baicalin ameliorates the level of CK, CK-MB, LDH and cTnT in a rat model of acute myocardial infarction
| Groups | CK (U/mL) | CK-MB (IU/L) | LDH (U/L) | cTnT (U/mL) |
|---|---|---|---|---|
| Control | 0.21 ± 0.04 | 81.23 ± 5.38 | 1668.34 ± 314.69 | 0.07 ± 0.05 |
| Isoflurane | 0.98 ± 0.07* | 218.44 ± 9.11* | 5913.33 ± 502.11* | 0.62 ± 0.07* |
| Low-dose | 0.81 ± 0.05 | 177.55 ± 8.84 | 4773.93 ± 446.55 | 0.56 ± 0.06 |
| Medium-dose | 0.66 ± 0.03# | 141.11 ± 7.31# | 4071.44 ± 411.92# | 0.38 ± 0.05# |
| High-dose | 0.47 ± 0.06# | 121.28 ± 5.78# | 3371.93 ± 331.41# | 0.26 ± 0.03# |
*
P < 0.01 vs. control group;
#
P < 0.01 vs. isoflurane group.
Control, Control group; Isoflurane, isoflurane-induced group; Low-dose baicalin, baicalin (1 mg/kg)-treated; Medium-dose baicalin, baicalin (10 mg/kg)-treated; High -dose baicalin, baicalin (100 mg/kg)-treated.